Cost Effectiveness of Denosumab Compared with Oral Bisphosphonates in the Treatment of Post-Menopausal Osteoporotic Women in Belgium

Author： Hiligsmann Mickaël Reginster Jean-Yves

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.29, Iss.10, 2011-10, pp. : 895-911

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost-effectiveness of denosumab in the treatment of postmenopausal osteoporotic women

By Hiligsmann Mickaël Boonen Annelies Dirksen Carmen D Sedrine Wafa Ben Reginster Jean-Yves

Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 13, Iss. 1, 2013-02 ,pp. : 19-28

Informa Healthcare

Access to resources Recommend Favorite

Denosumab for the Prevention of Osteoporotic Fractures in Post-Menopausal Women: A NICE Single Technology Appraisal

By Scotland Graham

PharmacoEconomics, Vol. 29, Iss. 11, 2011-11 ,pp. : 951-961

Adis International

Access to resources Recommend Favorite

A Cost-Effectiveness Model of Tibolone as Treatment for the Prevention of Osteoporotic Fractures in Postmenopausal Women in Sweden

By Willis M.

Clinical Drug Investigation, Vol. 21, Iss. 2, 2001-02 ,pp. : 115-127

Adis International

Access to resources Recommend Favorite

Magnesium, Zinc and Copper Status in Osteoporotic, Osteopenic and Normal Post-menopausal Women

By Mutlu M Argun M Kilic E Saraymen R Yazar S

The Journal of International Medical Research, Vol. 35, Iss. 5, 2007-09 ,pp. : 692-695

Field House Publishing

Access to resources Recommend Favorite

Cost Effectiveness of Letrozole in the Treatment of Advanced Breast Cancer in Postmenopausal Women in the UK

By Nuijten M.

PharmacoEconomics, Vol. 16, Iss. 4, 1999-10 ,pp. : 379-397

Adis International

Access to resources Recommend Favorite